These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3889723

  • 1. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
    Bossi L.
    Minerva Med; 1985 May 19; 76(21):1005-18. PubMed ID: 3889723
    [Abstract] [Full Text] [Related]

  • 2. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE, Meurer-Krüll BC.
    Arzneimittelforschung; 1985 May 19; 35(12):1865-70. PubMed ID: 3913425
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
    Kaemmerer E.
    Nervenarzt; 1980 Jun 19; 51(6):368-72. PubMed ID: 7453888
    [No Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of (-)eburnamonine in comparison with nicergoline in patients suffering from chronic brain ischemia.
    Marolda M, Fragassi N, Buscaino GA.
    Eur Neurol; 1978 Jun 19; 17 Suppl 1():159-66. PubMed ID: 381006
    [Abstract] [Full Text] [Related]

  • 5. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B, Hochmayer I, Grünberger J, Böhmer F, Paroubek J, Wicke L, Neuhold A.
    Wien Med Wochenschr; 1987 Nov 30; 137(22):513-24. PubMed ID: 3324497
    [Abstract] [Full Text] [Related]

  • 6. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].
    Cahn R, Weber S, Angignard J, Angignard D, Borzeix MG.
    Agressologie; 1987 Mar 30; 28(3):341-6. PubMed ID: 3618895
    [No Abstract] [Full Text] [Related]

  • 7. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
    Cascone A, Liverta C, Pollini C.
    Minerva Cardioangiol; 1978 Mar 30; 26(1-2):95-100. PubMed ID: 347330
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
    Karyofilis A.
    Ther Ggw; 1980 Dec 30; 119(12):1478-85. PubMed ID: 7466692
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of nicergoline on the intellectual performance (author's transl)].
    Donoso A, Santander M, Sarce H.
    Rev Med Chil; 1979 Sep 30; 107(9):817-9. PubMed ID: 396627
    [No Abstract] [Full Text] [Related]

  • 10. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM, Villa Badó J, Villalobos J, Iriarte JL, Ordeix R.
    Arzneimittelforschung; 1979 Sep 30; 29(8a):1301-7. PubMed ID: 540075
    [Abstract] [Full Text] [Related]

  • 11. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
    Colombeau P, Ballanger P.
    J Urol (Paris); 1987 Sep 30; 93(9-10):533-5. PubMed ID: 3327892
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
    Pogliani E, Recalcati P, Tantalo V, Bregnani P.
    Arzneimittelforschung; 1979 Sep 30; 29(8a):1266-9. PubMed ID: 395954
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
    Shtok VN, Varlamova IV, Fedorova NV, Timurbaator.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Sep 30; 85(9):1333-8. PubMed ID: 4072531
    [Abstract] [Full Text] [Related]

  • 16. [Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].
    Bente D, Glatthaar G, Ulrich G, Lewinsky M.
    Arzneimittelforschung; 1979 Sep 30; 29(11):1804-8. PubMed ID: 543890
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Action of Nicergoline (Sermion) in chronic vascular disease in old age].
    Michelangeli J, Sevilla M, Lavagna J, Darcourt G.
    Ann Med Psychol (Paris); 1975 Apr 30; 1(4):499-510. PubMed ID: 788599
    [No Abstract] [Full Text] [Related]

  • 19. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
    Blaha L, Burkard G, Lehrl S, Kapinas K.
    Arzneimittelforschung; 1979 Apr 30; 29(8a):1295-301. PubMed ID: 395955
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline.
    Le Poncin-Lafitte M, Grosdemouge C, Duterte D, Rapin JR.
    Gerontology; 1984 Apr 30; 30(2):109-19. PubMed ID: 6706123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.